
GC37897
Vernakalant
Also known as (3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol
Vernakalant(RSD-1235) is an investigational mixed ion channel blocker that can terminate acute atrial fibrillation (AF) in humans at 2 to 5 mg/kg and may be more atrial-selective than available agents; in treatment of antiarrhythmic
ChemicalCAS794466-70-9MW349.46FormulaC20H31NO4
- CAS number
- 794466-70-9
- Molecular weight
- 349.46
- Formula
- C20H31NO4
- Solubility
- Soluble in DMSO
- InChIKey
- VBHQKCBVWWUUKN-KZNAEPCWSA-N
- Catalogue number
- GC37897
- Brand
- GLPBIO
Computed properties PubChem CID 9930049 · XLogP 2.9 · TPSA 51.2 Ų · H-bond donors 1
- XLogP
- 2.9
- TPSA
- 51.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 7
- Heavy atoms
- 25
SMILES COC1=C(C=C(C=C1)CCO[C@@H]2CCCC[C@H]2N3CC[C@H](C3)O)OC
Computed descriptors from PubChem (CID 9930049), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il